Search

everythinglearnresearchcommunity

for

Search:↓

High levels of the protein Flightless I worsen ulcerative colitis symptoms in mice.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

Genomic approach finds new possible treatments for hair loss.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Low-Level Laser Therapy and other light treatments for hair growth lack strong evidence and need more research.

Allergies and atopic conditions may increase the risk of developing alopecia areata.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

Burn scars heal abnormally and more research is needed to find better treatments.

Collagen-heparin-FGF2-VEGF scaffolds can improve skin healing.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Adiponectin and bradykinin play important roles in skin health and may help treat skin conditions.

Combining Cyclosporine A with low-dose corticosteroids effectively treats severe alopecia areata.

Damaged hair follicles make mice more prone to skin inflammation and skin cancer after UV exposure.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

Epimedium extract helps increase skin pigmentation and could be a new treatment for conditions with reduced pigmentation.

The combined treatment with engineered bacteria and yellow LED light improved wound healing in mice.

Wnt5a may contribute to psoriasis by reducing skin cell growth, blocking skin cell maturation, and increasing inflammation.

Chicken feather gene mutation helps understand human hair disorders.

Nail loss may be a side effect of the MS drug teriflunomide.

SA linked to mitochondrial issues and oxidative stress, while AGA involves disrupted hair growth genes.

Electrospun scaffolds can improve healing in diabetic wounds.

Gut bacteria affect female reproductive health and may help diagnose and treat related diseases.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Putting thymidine dinucleotide on newborn mice's skin can delay and reduce skin cancer.

Combining baricitinib with UV-B therapy effectively treats non-segmental vitiligo and is well-tolerated.